{"doi":"10.7554/elife.67447","title":"Ribonucleotide reductase, a novel drug target for gonorrhea","abstract":"Antibiotic-resistant Neisseria gonorrhoeae (Ng ) are an emerging public health threat due to increasing numbers of multidrug resistant (MDR) organisms. We identified two novel orally active inhibitors, PTC-847 and PTC-672, that exhibit a narrow spectrum of activity against Ng including MDR isolates. By selecting organisms resistant to the novel inhibitors and sequencing their genomes, we identified a new therapeutic target, the class Ia ribonucleotide reductase (RNR). Resistance mutations in Ng map to the N-terminal cone domain of the α subunit, which we show here is involved in forming an inhibited α 4 β 4 state in the presence of the β subunit and allosteric effector dATP. Enzyme assays confirm that PTC-847 and PTC-672 inhibit Ng RNR and reveal that allosteric effector dATP potentiates the inhibitory effect. Oral administration of PTC-672 reduces Ng infection in a mouse model and may have therapeutic potential for treatment of Ng that is resistant to current drugs.","journal":"eLife","year":2022,"id":269940,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":14,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9569,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2022-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":573035,"name":"Suzanne Letinski","orcid":null,"position":1,"is_corresponding":false},{"id":572264,"name":"Stephen P. Jung","orcid":"0000-0002-9276-175X","position":2,"is_corresponding":false},{"id":934287,"name":"Aleksey Gerasyuto","orcid":null,"position":3,"is_corresponding":false},{"id":555371,"name":"Jiashi Wang","orcid":"0000-0003-3094-7628","position":4,"is_corresponding":false},{"id":474940,"name":"Michael Arnold","orcid":"0000-0002-6921-3720","position":5,"is_corresponding":false},{"id":934288,"name":"Guangming Chen","orcid":null,"position":6,"is_corresponding":false},{"id":573037,"name":"Jean Hedrick","orcid":null,"position":7,"is_corresponding":false},{"id":573038,"name":"Melissa Dumble","orcid":null,"position":8,"is_corresponding":false},{"id":573039,"name":"Kanchana Ravichandran","orcid":null,"position":9,"is_corresponding":false},{"id":934289,"name":"Talya Levitz","orcid":null,"position":10,"is_corresponding":false},{"id":241328,"name":"Chang Cui","orcid":"0000-0002-4709-7458","position":11,"is_corresponding":false},{"id":241330,"name":"Catherine L. Drennan","orcid":"0000-0001-5486-2755","position":12,"is_corresponding":false},{"id":262762,"name":"JoAnne Stubbe","orcid":"0000-0001-8076-4489","position":13,"is_corresponding":false},{"id":934290,"name":"Gary Karp","orcid":null,"position":14,"is_corresponding":false},{"id":572267,"name":"Arthur Branstrom","orcid":"0000-0002-5917-6372","position":15,"is_corresponding":false},{"id":572263,"name":"Jana Narasimhan","orcid":"0000-0001-5621-8592","position":0,"is_corresponding":true}],"reference_count":45,"raw_metadata":null,"created_at":"2026-07-19T00:27:26.772098Z","pmid":"35137690","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}